Trial Profile
The retrospective clinical study on inhibitory effect of 0.1% brimonidine ophthalmic solution against the optic disc hemorrhage
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 16 Mar 2017 New trial record